Literature DB >> 11335892

Concordance between the CC chemokine receptor 5 genetic determinants that alter risks of transmission and disease progression in children exposed perinatally to human immunodeficiency virus.

A Mangano1, E Gonzalez, R Dhanda, G Catano, M Bamshad, A Bock, R Duggirala, K Williams, S Mummidi, R A Clark, S S Ahuja, M J Dolan, R Bologna, L Sen, S K Ahuja.   

Abstract

If CC chemokine receptor 5 (CCR5)-dependent mechanisms at the time of initial virus exposure are important determinants of virus entry and disease outcome, then the polymorphisms in CCR5 that influence risk of transmission and disease progression should be similar; this hypothesis was tested in a cohort of 649 Argentinean children exposed perinatally to human immunodeficiency virus type 1 (HIV-1). Two lines of evidence support this hypothesis. First, CCR5 haplotype pairs associated with enhanced risk of transmission were the chief predictors of a faster disease course. Second, some of the haplotype pairs associated with altered rates of transmission and disease progression in children were similar to those that we previously found influenced outcome in European American adults. This concordance suggests that CCR5 haplotypes may serve as genetic rheostats that influence events occurring shortly after initial virus exposure, dictating not only virus entry but, by extension, also the extent of early viral replication.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11335892     DOI: 10.1086/320705

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic.

Authors:  E Gonzalez; R Dhanda; M Bamshad; S Mummidi; R Geevarghese; G Catano; S A Anderson; E A Walter; K T Stephan; M F Hammer; A Mangano; L Sen; R A Clark; S S Ahuja; M J Dolan; S K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  Association of CCR5Delta32 with reduced risk of childhood but not adult asthma.

Authors:  P Srivastava; P J Helms; D Stewart; M Main; G Russell
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

3.  CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro.

Authors:  Janelle R Salkowitz; Shannon E Bruse; Howard Meyerson; Hernan Valdez; Donald E Mosier; Clifford V Harding; Peter A Zimmerman; Michael M Lederman
Journal:  Clin Immunol       Date:  2003-09       Impact factor: 3.969

4.  Concordance of CCR5 genotypes that influence cell-mediated immunity and HIV-1 disease progression rates.

Authors:  Gabriel Catano; Zoya A Chykarenko; Andrea Mangano; J-M Anaya; Weijing He; Alison Smith; Rosa Bologna; Luisa Sen; Robert A Clark; Andrew Lloyd; Ludmila Shostakovich-Koretskaya; Sunil K Ahuja
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

5.  Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease.

Authors:  Jane C Burns; Chisato Shimizu; Enrique Gonzalez; Hemant Kulkarni; Sukeshi Patel; Hiroko Shike; Robert S Sundel; Jane W Newburger; Sunil K Ahuja
Journal:  J Infect Dis       Date:  2005-06-08       Impact factor: 5.226

6.  Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.

Authors:  Jianming Tang; Brent Shelton; Nina J Makhatadze; Yuting Zhang; Margaret Schaen; Leslie G Louie; James J Goedert; Eric C Seaberg; Joseph B Margolick; John Mellors; Richard A Kaslow
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Cis-regulatory genetic variants in the CCR5 gene and natural HIV-1 control in black South Africans.

Authors:  Gemma W Koor; Maria Paximadis; Anabela C P Picton; Fidan Karatas; Shayne A Loubser; Weijing He; Sunil K Ahuja; Richard E Chaisson; Neil Martinson; Osman Ebrahim; Caroline T Tiemessen
Journal:  Clin Immunol       Date:  2019-05-15       Impact factor: 3.969

8.  C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection.

Authors:  M Tevfik Dorak; Gbolahan O Folayan; Santosh Niwas; Dirk J van Leeuwen; Leland J Yee; Jianming Tang; Richard A Kaslow
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

9.  Association between HIV-1 tropism and CCR5 human haplotype E in a Caucasian population.

Authors:  Kristi Huik; Radko Avi; Helen Uibopuu; Merit Pauskar; Tõnu Margus; Tõnis Karki; Tõnu Krispin; Piret Kool; Kristi Rüütel; Ave Talu; Katri Abel-Ollo; Anneli Uusküla; Andrew Carrillo; Weijing He; Sunil K Ahuja; Irja Lutsar
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731

Review 10.  Genetics and the general physician: insights, applications and future challenges.

Authors:  J C Knight
Journal:  QJM       Date:  2009-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.